Journal · Updated 2026-08-11

How to Verify a GLP-1 Compounding Pharmacy's License: The 15-Minute Masterclass

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

Step one: get the name — the whole name

Verification runs on the exact legal entity, not the brand vibe. "Our licensed US pharmacy partner" is not a name. Before paying, ask the program directly: which pharmacy will fill my prescription, and in which state is it located? Legitimate programs answer — several in our database name their networks publicly, a transparency signal our pharmacy-network audits and the pharmacy-disclosure field on every provider record track. After your first shipment, the dispensing pharmacy's name, address, and phone number must appear on the prescription label itself — the label-reading guide shows exactly where. If the label names a different pharmacy than you were told, that is a question to ask in writing, and if the label names no pharmacy at all, stop: a US prescription label without a dispensing pharmacy is not a US prescription label.

Step two: the home-state license

Every state board of pharmacy operates a free license-verification portal, and the national association of boards (NABP) maintains a directory of all of them — searching a state's name plus "board of pharmacy license verification" lands on the right page in one query. Search the pharmacy's legal name in its home state and read three things. Status: you want active and unrestricted — words like "probation," "suspended," or "restricted" are the finding, not a formality. License type: it should be licensed as a pharmacy (and, if it sterile-compounds, many states show a sterile-compounding endorsement or separate permit). Discipline: most portals link disciplinary history or board orders; an order is not automatically disqualifying — read what it was for and when — but an undisclosed recent order about compounding quality is exactly what this step exists to surface. Our Hallandale worked example walks this step click by click on a real pharmacy.

Step three: the nonresident license in your state

This is the step almost everyone skips and the one that catches the most problems. Medication shipped to you in state X generally requires the pharmacy to hold a nonresident pharmacy license issued by state X's board — your board, not just its own. Run the same license search on your own state's portal. A pharmacy licensed at home but not licensed to ship into your state is, at minimum, a program that hasn't done its compliance homework for your address — and state boards have pursued exactly this violation against GLP-1 shippers. This check is also the practical explanation for why provider records list "states served": those maps are nonresident-licensure maps wearing a marketing hat.

Step four: 503A or 503B — and why the answer changes the checklist

The two lawful kinds of compounder are different animals, and our 503A versus 503B explainer is the full treatment. The short version: a 503A pharmacy compounds patient-specific prescriptions under state board oversight; a 503B outsourcing facility registers with FDA, follows federal manufacturing standards (CGMP), and is inspected by FDA. The verification consequence: a program claiming its pharmacy is a 503B is making a checkable claim — FDA publishes the list of registered outsourcing facilities on fda.gov and updates it regularly, and the facility either appears there or it doesn't. A 503A claim routes you back to the state board work in steps two and three. Either answer is compatible with a legitimate program in 2026; a program that can't tell you which kind fills its prescriptions is failing an easier question than the one you asked.

Step five: the record — letters, inspections, recalls, actions

Licensure says a pharmacy may operate; the record says how it has. Four searches, all free. FDA warning letters: FDA's searchable warning-letter database — search the pharmacy's name; a letter about sterility or potency at a compounder is a first-order finding, and our dated enforcement record tracks every 2025–2026 GLP-1 letter wave and what the citations actually say. Inspection findings: FDA publishes inspection classifications and many Form 483 observation reports; our Empower deep-dive shows how to read one without over- or under-reacting — observations are common, and the questions are what was observed, how serious, and what the response was. Recalls: FDA's recall database, same search. State actions: back to the board portals from steps two and three, disciplinary tab. Fifteen minutes total, and the asymmetry is the point: the pharmacies that pass this check pass it easily, and the ones that don't were exactly the ones the check existed for.

The checks beyond licensure

Two more artifacts complete the picture for compounded GLP-1s specifically. A certificate of analysis — the third-party lab document behind a given batch — is the potency-and-purity evidence; what a real one contains, and the tells of a decorative one, are in the COA guide. And the base-versus-salt question: FDA has specifically warned about compounded products using salt forms of semaglutide (and flagged unapproved forms generally); asking "is this the base form of the molecule" is a one-line email that legitimate pharmacies answer without friction. Neither artifact substitutes for licensure — a beautiful COA from an unlicensed shipper is decoration — which is why this guide runs in the order it does.

Red flags that end the check early

Some findings don't need the full fifteen minutes. No prescription required — a US pharmacy dispensing prescription GLP-1s without a prescription is describing a crime, not a convenience; close the tab. "FDA-approved compounded tirzepatide" — the phrase is always false; no compounded drug is FDA-approved, and a seller who doesn't know that (or hopes you don't) has told you about their other claims too. "Research use only" peptides — RUO vials are not medicine, carry no pharmacy, no prescriber, and no lawful human use; the gray-market analysis covers why that market's prices are low in the way that matters. Crypto-only or wire-only payment, no named prescriber, no intake questions — each is covered in the scam red-flags guide, and any one of them outranks every green flag on the page.

What this looks like done well

Worked end to end, the check produces a sentence you can write down: "My prescription is filled by [legal name], a [503A pharmacy / FDA-registered 503B facility] in [state], licensed and clear in its home state and licensed as a nonresident pharmacy in mine, with [no / the following] warning letters, recalls, or board actions on record, and a current COA available for my batch." Every bracket is checkable by anyone, for free, in an evening — which is the standard this site holds the programs in its price database to, and the reason a verified one-seventy-nine beats an unverifiable one-twenty-nine every single time.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.